REDWOOD CITY, Calif., Sept. 06, 2016 -- Codexis, Inc. (NASDAQ:CDXS), a leading protein engineering company, announces that management will present at three upcoming investment conferences:
- Rodman & Renshaw 18th Annual Global Investment Conference on Monday, September 12, 2016, at 5:05 p.m. Eastern time (2:05 p.m. Pacific time). The conference is being held at the New York Palace Hotel in New York City.
- 2016 KeyBanc Capital Markets’ Basic Materials & Packaging Conference on Wednesday, September 14, 2016. The conference is being held at the InterContinental Hotel in Boston.
- Ladenburg Thalmann 2016 Healthcare Conference on Tuesday, September 27, 2016, at 9:00 a.m. Eastern time (6:00 a.m. Pacific time). The conference is being held at the Sofitel Hotel in New York City.
A live webcast and replay of the presentations at the Rodman & Renshaw and Ladenburg Thalmann Conferences will be available on the Investors section of the company's website, http://ir.codexis.com/.
About Codexis, Inc.
Codexis, Inc. is a leading developer of biocatalysts for pharmaceutical and fine chemical production. The company’s patent portfolio includes more than 850 patents and patent applications worldwide that cover its novel enzymes and proprietary methods for engineering new enzymes and their applications. Codexis’ proven technology enables implementation of biocatalytic solutions to meet customer needs for rapid, cost-effective and sustainable manufacturing. For more information, see www.codexis.com.
Contacts:
Investors
LHA
Jody Cain, 310 691 7100
[email protected]
Media
That’s Nice LLC
Guy Tiene
[email protected]


Apple Explores India for iPhone Chip Assembly as Manufacturing Push Accelerates
Delta Air Lines President Glen Hauenstein to Retire, Leaving Legacy of Premium Strategy
Treasury Wine Estates Shares Plunge on Earnings Warning Amid U.S. and China Weakness
Maersk Vessel Successfully Transits Red Sea After Nearly Two Years Amid Ongoing Security Concerns
MetaX IPO Soars as China’s AI Chip Stocks Ignite Investor Frenzy
Toyota to Sell U.S.-Made Camry, Highlander, and Tundra in Japan From 2026 to Ease Trade Tensions
Republicans Raise National Security Concerns Over Intel’s Testing of China-Linked Chipmaking Tools
Apple Opens iPhone to Alternative App Stores in Japan Under New Competition Law
Harris Associates Open to Revised Paramount Skydance Bid for Warner Bros Discovery
Nike Shares Slide as Margins Fall Again Amid China Slump and Costly Turnaround
Oracle Stock Surges After Hours on TikTok Deal Optimism and OpenAI Fundraising Buzz
Shell M&A Chief Exits After BP Takeover Proposal Rejected
Blackstone Leads $400 Million Funding Round in Cyera at $9 Billion Valuation
Sanofi’s Efdoralprin Alfa Gains EMA Orphan Status for Rare Lung Disease
Elliott Management Takes $1 Billion Stake in Lululemon, Pushes for Leadership Change
Instacart Stock Drops After FTC Probes AI-Based Price Discrimination Claims
TikTok U.S. Deal Advances as ByteDance Signs Binding Joint Venture Agreement 



